11 September 2020 - In the drive towards faster patient access to treatments, health technology assessment agencies are increasingly faced with reliance on evidence from surrogate outcomes, leading to increased decision uncertainty.
This study undertook an updated survey of methodological guidance for using surrogate endpoints across international HTA agencies.
The authors reviewed health technology assessment and economic evaluation methods guidance from European, Australian and Canadian health technology assessment agencies.